Chugai started phase III clinical trial of Actemra for COVID-19 pneumonia in Japan
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
-
-
COVID-19 will likely lead to US drug shortages
On Mar. 27, 2020, researchers at the University of Minnesota reported that the COVID-19 pandemic stands a good…
-
Artificial Intelligence | Biotechnology | COVID-19 | Infectious Disease | Life Science History | Non-Profit Research | Pharmaceutical | Therapeutics
COVID-19 first target of new AI research consortium
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics | WHO
WHO Director-General calls on G20 to fight, unite, and ignite against COVID-19
On Mar. 26, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), addressed Heads of…
-
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, an international project aimed to enroll 500 COVID-19 patients to search for genetic mutations…
-
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Oxford University’s COVID-19 research received government funding
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Infectious Disease | Pharmaceutical | Therapeutics
BioSig subsidiary NeuroClear acquired license for a broad-spectrum anti-viral agent that may treat COVID-19
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
-
Biotechnology | Diagnostics | Medicine | NIH | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
-
COVID-19 pandemic drove accelerated demand for Covetrus online pharmacy services
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
-
Artificial Intelligence | Biotechnology | COVID-19 | FDA | Infectious Disease | Oncology | Pharmaceutical | Therapeutics
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
-
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
-
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
-
Biotechnology | Disease | FDA | Neurology | Pharmaceutical | Therapeutics
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
-
BioMotiv and Bristol-Myers Squibb announced the Launch of Anteros Pharmaceuticals
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
-
Alexion completed acquisition of Achillion for $930 million
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
-
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
-
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
-
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
-
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
-
Chembio Diagnostics and Takeda Pharmaceutical announced collaboration to develop point-of-care diagnostic test
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
-
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
-
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
-
AstraZeneca closed Boulder-based LakeCentre and Longmont facilities
On Jan. 9, 2019, pharmaceutical company AstraZeneca announced it was laying off more than 200 employees in Boulder…
-
Takeda Pharmaceutical acquired Shire for $62 Billion
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
-
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
-
Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
-
Agriculture | Biotechnology | Life Science History | Medical Device | Nanotechnology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | Veterinary
Arizona Life Science Genealogy Published
On Aug. 9, 2018, Arizona Life Science Genealogy was published illustrating life science companies and non-profit research organization…
-
Teva Pharmaceuticals announced North America headquarters moved to New Jersey
On Jul. 6, 2018, Teva Pharmaceuticals formalized its commitment to consolidate its North America Commercial business areas into…
-
Agriculture | Biotechnology | Life Science History | Medical Device | Nanotechnology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | Veterinary
Wisconsin Life Science Genealogy, 2018
On Jun. 1, 2018, Wisconsin Life Science Genealogy illustrates life science companies and non-profit research organization in the…
-
Agriculture | Biotechnology | Life Science History | Medical Device | Nanotechnology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | Veterinary
Washington Life Science Genealogy, 2018
On Jun. 1, 2018, Washington Life Science Genealogy was published illustrating life science companies and non-profit research organization…
